Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| May 1 | AVLN | Avalyn Pharma Inc. | PBUY | 277,778 | $18.00 | $5M | +14.5% | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV | 489,486 | — | — | +34.5% | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV | 1.4M | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 9,174 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 8,011 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 11,459 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | UTENDR | 1.5M | — | — | -100.0% | Open the original filing on SEC.gov |
| May 29, 2025 | ACLX | Arcellx, Inc. | AGRANT◆ | 9,174 | — | — | — | Open the original filing on SEC.gov |